Chen Kai, Hu Yan-Yan, Wang Lin-Lin, Xia Yun, Jiang Qian, Sun Lan, Qian Shan-Shan, Wu Jin-Zhao, Chen Liu-Qing, Li Dong-Sheng
Hubei Key Laboratory of Infectious and Immune Skin Diseases, Wuhan No. 1 Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Department of Dermatology, Wuhan No. 1 Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Front Med (Lausanne). 2022 Jul 20;9:905902. doi: 10.3389/fmed.2022.905902. eCollection 2022.
Port-wine stains (PWSs) are a congenital capillary malformed disorder and are caused by a number of somatic mutations that disrupt vascular development. However, the underlying genetic mutations in the pathogenesis of PWS have not yet been fully elucidated. To understand PWS genetic variations and investigate novel genetic mutations, we extracted genomic DNA from four sporadic PWS patients and then performed whole-genome sequencing (WGS). Using Sorting Intolerant from Tolerant (SIFT), PolyPhen2, Mutation Assessor, MetaSVM to identify candidate genetic mutations and whole-exome sequencing (WES) to confirm the identified variants. We found a previously reported G protein subunit alpha q (GNAQ) mutation c.548G > A, p.Arg183Gln in one case, whereas no such mutation was found in the other three samples. Moreover, six novel somatic mutations in three genes, including , , , were found in these four samples. Importantly, WES also verified the (c.433G > A, p.Gly145Ser) and (c.413G > A, p.Arg138His) mutations in other five sporadic PWS patients, with the frequency of 60% (3 of 5) and 40% (2 of 5), respectively. Thus, we reveal in this study two novel somatic mutations, and , in the sporadic PWS patients for the first time. These findings highlight the genetic polymorphism of PWS and provide potential clinical prediction targets for this disease.
葡萄酒色斑(PWSs)是一种先天性毛细血管发育畸形疾病,由多种破坏血管发育的体细胞突变引起。然而,PWS发病机制中的潜在基因突变尚未完全阐明。为了了解PWS的基因变异并研究新的基因突变,我们从4例散发性PWS患者中提取了基因组DNA,然后进行了全基因组测序(WGS)。使用从耐受中筛选不耐受(SIFT)、PolyPhen2、突变评估器、MetaSVM来识别候选基因突变,并通过全外显子组测序(WES)来确认所识别的变异。我们在1例病例中发现了先前报道的G蛋白亚基αq(GNAQ)突变c.548G>A,p.Arg183Gln,而在其他3个样本中未发现此类突变。此外,在这4个样本中发现了3个基因中的6个新的体细胞突变,包括 、 、 。重要的是,WES还在其他5例散发性PWS患者中验证了 (c.433G>A,p.Gly145Ser)和 (c.413G>A,p.Arg138His)突变,频率分别为60%(5例中的3例)和40%(5例中的2例)。因此,我们在本研究中首次在散发性PWS患者中发现了两个新的体细胞突变, 和 。这些发现突出了PWS的基因多态性,并为该疾病提供了潜在的临床预测靶点。